Endo Y - Search Results

1

Active conformation of a tumor promoter, teleocidin. A molecular dynamics study.

Kawai T, Ichinose T, Endo Y, Shudo K, Itai A. Kawai T, et al. Among authors: endo y. J Med Chem. 1992 Jun 12;35(12):2248-53. doi: 10.1021/jm00090a016. J Med Chem. 1992. PMID: 1613749

2

Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.

Endo Y, Takehana S, Ohno M, Driedger PE, Stabel S, Mizutani MY, Tomioka N, Itai A, Shudo K. Endo Y, et al. J Med Chem. 1998 Apr 23;41(9):1476-96. doi: 10.1021/jm970704s. J Med Chem. 1998. PMID: 9554881

3

Synthesis, computer modeling and biological evaluation of novel protein kinase C agonists based on a 7-membered lactam moiety.

Endo Y, Shimazu M, Fukasawa H, Driedger PE, Kimura K, Tomioka N, Itai A, Shudo K. Endo Y, et al. Bioorg Med Chem Lett. 1999 Jan 18;9(2):173-8. doi: 10.1016/s0960-894x(98)00724-0. Bioorg Med Chem Lett. 1999. PMID: 10021922

4

[The active conformation of teleocidins: design and synthesis of new active molecules].

Endo Y, Ohno M, Shudo K. Endo Y, et al. Yakugaku Zasshi. 1994 Jul;114(7):464-77. doi: 10.1248/yakushi1947.114.7_464. Yakugaku Zasshi. 1994. PMID: 7932093 Review. Japanese.

5

A receptor model for tumor promoters: rational superposition of teleocidins and phorbol esters.

Itai A, Kato Y, Tomioka N, Iitaka Y, Endo Y, Hasegawa M, Shudo K, Fujiki H, Sakai S. Itai A, et al. Among authors: endo y. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3688-92. doi: 10.1073/pnas.85.11.3688. Proc Natl Acad Sci U S A. 1988. PMID: 3131760 Free PMC article.

6

Twist form of teleocidin derivatives is active in in vivo tumor promotion by (-)-benzolactam-V8-310.

Okabe S, Sueoka N, Komori A, Suganuma M, Endo Y, Shudo K, Fujiki H. Okabe S, et al. Among authors: endo y. Biol Pharm Bull. 1998 May;21(5):465-8. doi: 10.1248/bpb.21.465. Biol Pharm Bull. 1998. PMID: 9635501 Free article.

7

Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore.

Endo Y, Iijima T, Yamakoshi Y, Yamaguchi M, Fukasawa H, Shudo K. Endo Y, et al. J Med Chem. 1999 May 6;42(9):1501-4. doi: 10.1021/jm9900725. J Med Chem. 1999. PMID: 10229620 No abstract available.

8

Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore.

Endo Y, Yoshimi T, Kimura K, Itai A. Endo Y, et al. Bioorg Med Chem Lett. 1999 Sep 6;9(17):2561-4. doi: 10.1016/s0960-894x(99)00436-9. Bioorg Med Chem Lett. 1999. PMID: 10498208

9

Structure-activity study of estrogenic agonists bearing dicarba-closo-dodecaborane. Effect of geometry and separation distance of hydroxyl groups at the ends of molecules.

Endo Y, Iijima T, Amakoshi Y, Kubo A, Itai A. Endo Y, et al. Bioorg Med Chem Lett. 1999 Dec 6;9(23):3313-8. doi: 10.1016/s0960-894x(99)00596-x. Bioorg Med Chem Lett. 1999. PMID: 10612591

10

Enhancing effect of tumor promoters, phorbol esters and teleocidins on nuclear receptor-mediated transcription.

Fukasawa H, Yamaguchi M, Hashimoto Y, Endo Y, Shudo K. Fukasawa H, et al. Among authors: endo y. Biol Pharm Bull. 2000 Dec;23(12):1414-7. doi: 10.1248/bpb.23.1414. Biol Pharm Bull. 2000. PMID: 11145168 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,398 results

Search Page

Filters